Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|6|1|155-161

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.6, Iss.1, 2018-01, pp. : 155-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myeloproliferative neoplasms

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 34-33

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

By Keam Susan J.  

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia†

By McCormack Paul L.   Keam Susan J.  

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 61-64

Adis International

Access to resources Recommend Favorite

A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide

By  

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 551-552

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Bullous Disease of Childhood in a Patient with Acute Lymphoblastic Leukemia: Possible Induction by a Drug

By Polat Muhterem  

American Journal of Clinical Dermatology, Vol. 8, Iss. 6, 2007-01 ,pp. : 389-391

Adis International

Access to resources Recommend Favorite